<?xml version="1.0" encoding="UTF-8"?>
<p>Despite widespread expression of ACE2 in pancreatic tissues, pancreatitis has been uncommon with coronavirus infections. No events of pancreatitis have been described during the SARS-CoV-1 or MERS-CoV epidemics attributable to the viral infection. During the current COVID-19 pandemic, mild pancreatitis (diagnosed on the basis of elevated serum amylase and/or lipase) has been described in patients with severe COVID-19 [
 <xref rid="CIT0093" ref-type="bibr">93</xref>]. It is uncertain whether the mild pancreatic injury was a result of direct viral invasion or the systemic inflammatory response. Nevertheless, it is important to recognize this because pancreatitis itself could worsen ARDS, the major life-threatening sequelae of COVID-19.
</p>
